Cancer Genetics Expands Its Industry-Leading Immuno-Oncology Panel, Complete::IO™, to be the Most Comprehensive for Immune Profiling & Monitoring

17 Jan 2018 - Yahoo News
-Simultaneously Assesses 27 Unique Immune Markers. -Determines Optimal IO Therapies and Tracks Response and Resistance Mechanisms. RUTHERFORD, N.J., Jan. 17, 2018-- Cancer Genetics, Inc., a leader in enabling ...
usx:cgix

---

TMO’s Oncomine Dx Target Test Gets CMS Coverage

29 Dec 2017 - Yahoo News
On December 7, 2017, Thermo Fisher Scientific (TMO) announced that its Oncomine Dx Target Test had been proposed for coverage by the CMS (Centers for Medicare & Medicaid Services).
usx:cgix

---

Cancer Genetics Receives Non-Dilutive Funding of $1.1 Million through New Jersey Technology Business Tax Certificate Transfer (NOL) Program

28 Dec 2017 - Yahoo News
RUTHERFORD, N.J., Dec. 28, 2017-- Cancer Genetics, Inc., a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced that the company has received $1.1 ...
usx:cgix

---

Cancer Genetics Receives New York State Approval for FDA-Approved Oncomine Dx Target Test by Thermo Fisher Scientific

19 Dec 2017 - Yahoo News
The test serves as a companion diagnostic for three targeted therapies in non-small cell lung cancer. Global NSCLC diagnostic market projected to reach $3.65 billion by 2024. RUTHERFORD, N.J., Dec. 19, ...
usx:cgix

---

Health Care Sector Update for 12/19/2017: CGIX,TMO,PFNX,JAZZ,THC

19 Dec 2017 - Nasdaq
Top Health Care StocksTop Health Care Stocks JNJ 0 03 JNJ 0 03 PFE 0 08 PFE 0 08 ABT 0 66 ABT 0 66 MRK 0 28 MRK 0 28 AMGN 0 38 AMGN 0 38 Health care stocks were narrowly lower Tuesday including a slightly more than 0 1 decline for the NYSE Health Care Index Shares of health
usx:cgix usx:pfnx

---

ETFs with exposure to Cancer Genetics, Inc. : December 18, 2017

18 Dec 2017 - Yahoo News
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cancer Genetics, Inc. Here are 5 ETFs with the largest exposure to CGIX-US. Comparing the performance and risk of Cancer Genetics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give ...
usx:cgix

---

Cancer Genetics, Inc. :CGIX-US: Earnings Analysis: Q3, 2017 By the Numbers : December 18, 2017

18 Dec 2017 - Yahoo News
Categories: Yahoo FinanceGet free summary analysis Cancer Genetics, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Cancer Genetics, Inc. – Trovagene, Inc., Enzo Biochem, Inc. and Genomic Health, Inc. (TROV-US, ENZ-US ...
usx:cgix

---

Blog Exposure - Cancer Genetics Announces Best Diagnostic Modality to Evaluate PD-L1 in Diffuse Large B-Cell Lymphomas

13 Dec 2017 - Yahoo News
Stock Monitor: Enzo Biochem Post Earnings Reporting LONDON, UK / ACCESSWIRE / December 13, 2017 / Active-Investors issued a free report on Cancer Genetics, Inc. (NASDAQ: CGIX ), which is readily accessible ...
usx:cgix usx:enz

---

Cancer Genetics advances understanding of immune response and measurement in lymphomas by combining PD-L1 expression analysis with RNA analysis

11 Dec 2017 - Yahoo News
Study Presented at the 59 th American Society of Hematology Annual Meeting Study focused on DLBCL. RUTHERFORD, N.J., Dec. 11, 2017-- Cancer Genetics, Inc., a leader in enabling precision medicine for oncology ...
usx:cgix

---